Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe M Loiseau

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
International Journal for Parasitology. Drugs and Drug Resistance|June 28, 2024
Effect of Phlebotomus papatasi on the fitness, infectivity and antimony-resistance phenotype of antimony-resistant Leishmania major Mon-25Nalia Mekarnia, Kamal-Eddine Benallal, Jovana Sádlová, et al.
International Journal of Pharmaceutics|June 17, 2020
A TLR9-adjuvanted vaccine formulated into dissolvable microneedle patches or cationic liposomes protects against leishmaniasis after skin or subcutaneous immunizationJuliane S Lanza, Sonja Vucen, Olivia Flynn, et al.
European Journal of Medicinal Chemistry|June 4, 2013
Synthesis of novel guttiferone A derivatives: in-vitro evaluation toward Plasmodium falciparum, Trypanosoma brucei and Leishmania donovaniYann Fromentin, Nicolas Gaboriaud-Kolar, Bruno Ndjakou Lenta, et al.
Molecules (Basel, Switzerland)|July 2, 2016
In Silico Mining for Antimalarial Structure-Activity Knowledge and Discovery of Novel Antimalarial CurcuminoidsBirgit Viira, Thibault Gendron, Don Antoine Lanfranchi, et al.
Experimental Parasitology|August 4, 2018
In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsionAndreza Rochelle do Vale Morais, André Leandro Silva, Sandrine Cojean, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 17, 2022
Targeting chalcone binding sites in living Leishmania using a reversible fluorogenic benzochalcone probeAriane S Batista, Suellen D S Oliveira, Sébastien Pomel, et al.
Pharmaceutics|August 26, 2022
Nanoassemblies from Amphiphilic Sb Complexes Target Infection Sites in Models of Visceral and Cutaneous LeishmaniasesJuliane S Lanza, Virginia M R Vallejos, Guilherme S Ramos, et al.
Molecules (Basel, Switzerland)|April 13, 2024
Chemoselective Synthesis and Anti-Kinetoplastidal Properties of 2,6-Diaryl-4<i>H</i>-tetrahydro-thiopyran-4-one <i>S</i>-Oxides: Their Interplay in a Cascade of Redox Reactions from DiarylideneacetonesThibault Gendron, Don Antoine Lanfranchi, Nicole I Wenzel, et al.
Journal of Ethnopharmacology|September 10, 2017
Antiprotozoal activity of medicinal plants used by Iquitos-Nauta road communities in Loreto (Peru)Pedro Vásquez-Ocmín, Sandrine Cojean, Elsa Rengifo, et al.
Molecules (Basel, Switzerland)|April 17, 2019
Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-TargetsStrahinja Stevanovic, Milan Sencanski, Mathieu Danel, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
International Journal for Parasitology. Drugs and Drug Resistance|June 28, 2024
Effect of Phlebotomus papatasi on the fitness, infectivity and antimony-resistance phenotype of antimony-resistant Leishmania major Mon-25Nalia Mekarnia, Kamal-Eddine Benallal, Jovana Sádlová, et al.
International Journal of Pharmaceutics|June 17, 2020
A TLR9-adjuvanted vaccine formulated into dissolvable microneedle patches or cationic liposomes protects against leishmaniasis after skin or subcutaneous immunizationJuliane S Lanza, Sonja Vucen, Olivia Flynn, et al.
European Journal of Medicinal Chemistry|June 4, 2013
Synthesis of novel guttiferone A derivatives: in-vitro evaluation toward Plasmodium falciparum, Trypanosoma brucei and Leishmania donovaniYann Fromentin, Nicolas Gaboriaud-Kolar, Bruno Ndjakou Lenta, et al.
Molecules (Basel, Switzerland)|July 2, 2016
In Silico Mining for Antimalarial Structure-Activity Knowledge and Discovery of Novel Antimalarial CurcuminoidsBirgit Viira, Thibault Gendron, Don Antoine Lanfranchi, et al.
Experimental Parasitology|August 4, 2018
In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsionAndreza Rochelle do Vale Morais, André Leandro Silva, Sandrine Cojean, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 17, 2022
Targeting chalcone binding sites in living Leishmania using a reversible fluorogenic benzochalcone probeAriane S Batista, Suellen D S Oliveira, Sébastien Pomel, et al.
Pharmaceutics|August 26, 2022
Nanoassemblies from Amphiphilic Sb Complexes Target Infection Sites in Models of Visceral and Cutaneous LeishmaniasesJuliane S Lanza, Virginia M R Vallejos, Guilherme S Ramos, et al.
Molecules (Basel, Switzerland)|April 13, 2024
Chemoselective Synthesis and Anti-Kinetoplastidal Properties of 2,6-Diaryl-4<i>H</i>-tetrahydro-thiopyran-4-one <i>S</i>-Oxides: Their Interplay in a Cascade of Redox Reactions from DiarylideneacetonesThibault Gendron, Don Antoine Lanfranchi, Nicole I Wenzel, et al.
Journal of Ethnopharmacology|September 10, 2017
Antiprotozoal activity of medicinal plants used by Iquitos-Nauta road communities in Loreto (Peru)Pedro Vásquez-Ocmín, Sandrine Cojean, Elsa Rengifo, et al.
Molecules (Basel, Switzerland)|April 17, 2019
Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-TargetsStrahinja Stevanovic, Milan Sencanski, Mathieu Danel, et al.
Pageof 12